NTI 1.89% 5.4¢ neurotech international limited

Ann: Successful Completion of In Vitro Studies, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 350 Posts.
    lightbulb Created with Sketch. 76
    Have you thoroughly read?
    "“These final trial results are very encouraging, in particular, the powerful anti-inflammatory mode of
    action of our strains compared to CBD alone,” said Brian Leedman, Chairman of Neurotech. These
    results demonstrate that the DOLCE/NTI leads may have a broader application in relation to the
    management and treatment of a number of neurological disorders”."
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.